Ausgabe 3/2012
Inhalt (14 Artikel)
Time to incorporate time in cost-effectiveness analysis
Gijs van de Wetering, Willem H. Woertman, Eddy M. Adang
Smoking bans and the secondhand smoking problem: an economic analysis
Annette Hofmann, Martin Nell
Incremental net benefit and acceptability of alternative health policies: a case study of mass screening for colorectal cancer
Pauline Chauvin, Jean-Michel Josselin, Denis Heresbach
I feel good! Gender differences and reporting heterogeneity in self-assessed health
Udo Schneider, Christian Pfarr, Brit S. Schneider, Volker Ulrich
Socioeconomic analysis of patient-centric networks: effects of patients and hospitals’ characteristics and network structure on hospitalization costs
Alireza Abbasi, Shahadat Uddin, Liaquat Hossain
The demand for sports and exercise: results from an illustrative survey
Nana Kwame Anokye, Subhash Pokhrel, Martin Buxton, Julia Fox-Rushby
Cancer patients’ willingness to pay for blood transfusions at home: results from a contingent valuation study in a French cancer network
Nathalie Havet, Magali Morelle, Raphaël Remonnay, Marie-Odile Carrere
Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data
Maria-Isabel Farfan-Portet, Carine Van de Voorde, France Vrijens, Robert Vander Stichele
Patient socioeconomic determinants for the choice of the cheapest molecule within a cluster: evidence from Belgian prescription data
France Vrijens, Carine Van de Voorde, Maria-Isabel Farfan-Portet, Robert Vander Stichele
Formal and informal care for disabled elderly living in the community: an appraisal of French care composition and costs
Alain Paraponaris, Bérengère Davin, Pierre Verger
Impact of healthcare reforms on out-of-pocket health expenditures in Turkey for public insurees
Burcay Erus, Nazli Aktakke
Association of antipsychotic polypharmacy with health service cost: a register-based cost analysis
Lone Baandrup, Jan Sørensen, Henrik Lublin, Merete Nordentoft, Birte Glenthoj
Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany
Galin V. Michailov, Glenn M. Davies, Karl J. Krobot